Guillain–Barré Syndrome Associated with SARS-CoV-2
Синдром Гийена—Барре, ассоциированный с SARS-CoV-2
2020-04-17
SCID: 54.1/n6h9rbt5
Discuss with AI
COVID-19 associated GBSGuillain–Barré syndromeSARS-CoV-2axonal patternpost-infectious neuropathy
Figures from the paper
Abstract (AI)
Guillain–Barre Syndrome with Covid-19 Five patients who had Guillain–Barre syndrome 5 to 10 days after the onset of Covid-19 are described. Three had severe weakness and an axonal pattern on electr...
Key Findings
1
Five patients developed Guillain–Barré syndrome (GBS) 5 to 10 days after onset of COVID-19 symptoms.
2
Temporal association suggests SARS-CoV-2 infection can be followed by GBS within about one week.
3
Three of the five patients had severe weakness with an axonal pattern on electrophysiologic studies.
Research Object
Guillain–Barré syndrome cases occurring in patients after SARS-CoV-2 (Covid-19) infection
Research Subject
Clinical and electrophysiological features (timing 5–10 days post–Covid-19 onset, severity of weakness, axonal electrophysiological pattern) of Guillain–Barré syndrome associated with SARS-CoV-2
Publication Details
Publication Date
2020-04-17
Journal
Publisher
ISSN
Cited by
1270
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
Cited by11
Neurological associations of COVID-192020
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings2020
Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-22020
Neurological and Neuropsychiatric Impacts of COVID-19 Pandemic2020
COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside2020
Invited Review: The spectrum of neuropathology in COVID‐192020
Neurological complications and infection mechanism of SARS-CoV-22021
SARS‐CoV‐2 and the brain: A review of the current knowledge on neuropathology in COVID‐192021
Miller‐Fisher syndrome after SARS‐CoV‐2 infection2020
Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung2021
THE NERVOUS SYSTEM DAMAGE IN COVID-19 PATIENTS2020